Status:
COMPLETED
Safety and Efficacy of Longan and Lingzhi Mushroom Syrup on Immune and Inflammatory Responses in Healthy Volunteers
Lead Sponsor:
Chulalongkorn University
Conditions:
Safety Issues
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This study aimed to preliminarily determine safety and efficacy of longan and lingzhi mushroom syrup on immune and inflammatory responses. Apparently healthy Thai adults (N = 8) aged 18-60 years were ...
Eligibility Criteria
Inclusion
- Apparently healthy adults at Mae Fah Luang University and Chulalongkorn University
- aged 18-60 years
- HbA1c \< 7%
Exclusion
- self-reported immunodeficiency diseases, autoimmune diseases, infectious diseases, diabetes, thyroid diseases, cancer, hepatic- and/or renal dysfunction, uncontrollable illnesses and life-threatening diseases
- being allergic to longan and lingzhi products
- taking medications, herbs, and diet supplements affecting immune system, inflammatory response, and blood glucose a month before study enrollment
- pregnant and breastfeeding women
Key Trial Info
Start Date :
February 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2020
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04728009
Start Date
February 1 2020
End Date
May 15 2020
Last Update
January 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn Unviersity
Bangkok, Thailand, 10310